FDA FY 2027: $7.227B budget, $3.9B fees, chemicals push

CIVA Public Health Desk
May 27, 2026 · Food and Drug Administration

This brief covers FDA’s FY 2027 budget notes, including toplines, fee financing, proposed new fees, food chemicals investments, inspection capacity changes, and the toxicology research center move described.

Command Box

The Move

Review FDA FY 2027 fee, inspection, and food chemicals changes against your food, pharmacy, and compliance exposure.

Primary Owner

Compliance

Secondary Reviewers

Finance, Regulatory Affairs, Supply Chain, Food and Nutrition

Time Sensitivity

This week

Why Now

The notes describe a proposed new fee, inspection capacity investments, and a funded food chemicals lane that could change oversight expectations.

Suggested Internal Note

FDA’s FY 2027 budget increases fee-backed oversight and funds food chemicals and inspection work; we should check exposure across food programs, supplier controls, and compliance readiness.

Executive Summary

Topline

FDA total program level is listed at $7.227B, described as +$232M vs FY 2026, with discretionary budget authority listed at $3.3B (−$48M).

Fees

Total user fees are listed at $3.9B and include a proposed $71M Food Facility and Importer Registration Fee.

Food chemicals

The notes describe $57M for FDA and MAHA food chemicals work: $50M to remove unsafe chemicals, $2M for AI/ML initiatives, and $5M for alternatives to animal testing.

Inspections

The notes describe inspection-related funding, including $9M for state-led routine inspections, $9M for training and domestic inspection capacity, $2M to expand the foreign office footprint, and $9M tied to imported food inspection efficiency.

Toxicology move

The notes describe relocating FDA’s National Center for Toxicological Research to CDC’s National Center for Chemicals and Toxins.

Drug shortages

The notes describe $9M for an FDA PreCheck Program tied to domestic manufacturing capacity and drug shortage resilience.

Coverage

This brief summarizes FDA FY 2027 budget items described in the notes, including toplines and staffing, fee financing and a proposed new registration fee, food chemicals investments, inspection capacity lines, the PreCheck program, and the National Center for Toxicological Research relocation.

What Changed

Funding and staffing

Program level is listed at $7.227B (+$232M vs FY 2026), discretionary budget authority is listed at $3.3B (−$48M), and staffing is listed at 18,174 FTE (+117).

Fee-backed operating model

User fees are listed at $3.9B and include a proposed $71M Food Facility and Importer Registration Fee.

Food chemicals lane

The notes describe $57M for FDA and MAHA food chemicals work, including $50M to remove unsafe chemicals, $2M for AI/ML initiatives, and $5M for alternatives to animal testing.

Inspection and training

The notes describe $9M for state-led routine inspections, $9M for training and domestic inspection capacity, $2M to expand foreign offices, and $9M to improve inspection efficiency and trust in imported food.

Toxicology governance shift

The notes describe moving the National Center for Toxicological Research from FDA to CDC’s National Center for Chemicals and Toxins.

Operational Implications

These scenarios identify which teams may need to assess exposure tied to FDA fee financing, inspection posture, and food chemicals oversight described in the FY 2027 notes.

If you manage food safety programs or nutrition operations
Review food chemicals exposure because the notes describe a $57M package, including $50M to remove unsafe chemicals and activity tied to ingredient safety and dyes.
Food and Nutrition Compliance Procurement
If you oversee regulatory or audit readiness
Review inspection readiness because the notes describe added funding for domestic inspections, training, and imported food inspection efficiency.
Regulatory Affairs Quality Compliance
If you manage pharmacy supply chain constraints
Review drug shortage mitigation plans because the notes describe $9M for an FDA PreCheck Program tied to domestic manufacturing capacity.
Pharmacy Supply Chain Quality

Command Checklist

Use this checklist to assign owners and document exposure. Progress resets when you leave the page.

Confirm the FY 2027 toplines and fee mix described (program level, discretionary BA, and user fees)
Review the proposed $71M Food Facility and Importer Registration Fee for potential operational impact
Document how your food programs would respond to the $57M food chemicals lane described
Update inspection readiness notes based on the domestic and imported food inspection funding lines described
Document NCTR move implications for toxicology dependencies and partner expectations described
Share a one-sentence internal note summarizing the FDA FY 2027 oversight posture described
0 of 6 reviewed
↺ Reset checklist

Who Should Read This

Food and nutrition leaders tracking food chemicals and ingredient safety oversight
Compliance and quality teams monitoring inspection and enforcement posture
Supply chain and pharmacy teams tracking drug shortage and manufacturing programs
Finance teams reviewing fee-backed operating model and proposed new fees

Sources


This report was generated by CIVA utilizing human-led calibration + AI architecture. Not a generic AI output. Provide feedback.